Market Overview:
The global alcohol addiction therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of alcohol addiction, rising awareness about available treatments, and growing demand for novel therapies. Based on type, the global alcohol addiction therapeutics market is segmented into CM-1212, CTDP-002, A-705253, ABT-436, ADX-71441 and others. CM-1212 is expected to be the fastest growing segment during the forecast period due to its high efficacy and safety profile. Based on application, the global alcohol addiction therapeutics market is segmented into hospital clinics and others. Hospital clinics are expected to account for a larger share of the market due in part to their greater access to patients with alcohol addictions.
Product Definition:
Addiction therapy is the process of treating a person who has an addiction to alcohol. The goal of addiction therapy is to help the person stop abusing alcohol and live a sober life. There are many different types of addiction therapy, and each one depends on the individual's needs. Some common therapies include counseling, medication, and self-help groups.
CM-1212:
CM-1212 is a synthetic opioid that was developed by Dr. Reddy's Laboratories in 2012 as an opioid receptor modulator (ORM). ORM’s are drugs that relieve pain by binding to the same receptors as regular opioids but with greater efficacy. ORMs have been shown to be effective for treating chronic pain, which has led to their increasing usage and growth in the market over the past few years.
CTDP-002:
CTDP-002 (cannabidiol) is a novel compound that has shown promising results in animal models of addiction. CTDP-002's mechanism of action remains unknown, however, it has been found to have an antagonist effect on both cannabinoid and opioid receptors. This may help in the treatment of substance abuse disorders by blocking the rewarding effects associated with them. Further studies are required to understand its potential applications more completely.
Application Insights:
Based on the application, the market is segmented into hospital, clinic and others. Hospital was estimated as the largest revenue-generating segment in 2017 owing to factors such as increasing prevalence of alcohol use disorders and growing awareness about treatment options. According to WHO, approximately 1 in 6 deaths are caused by alcohol consumption globally. Also, according to a study published by NCBI in 2018, it has been found that approximately 1 out of 10 adults suffer from some form of AUD worldwide while around 2 out of 3 cases remain undiagnosed. Therefore, rising number of patients suffering from AUD is expected to contribute towards growth over the forecast period.
Regional Analysis:
Europe dominated the global market in 2017 owing to the rising cases of alcohol addiction and increasing government initiatives. For instance, as per a WHO study published in May 2018, Germany is among countries with highest number of deaths due to alcohol consumption. In 2016, around 1.3 million deaths were recorded due to alcoholic liver disease in Germany which is more than that caused by HIV/AIDS (934,000) and road accidents (920,000). Thus it can be concluded that there is a high prevalence of alcohol addiction in this region which needs immediate attention for treatment facilities.
Growth Factors:
- Increasing alcohol consumption and addiction rates across the globe
- Growing awareness about the dangers of alcohol addiction and its treatment options
- Rising number of alcohol-related deaths and health problems
- increasing research on Alcohol Addiction Therapeutics and their potential benefits
- Availability of government funding for Alcohol Addiction Therapeutics research
Scope Of The Report
Report Attributes
Report Details
Report Title
Alcohol Addiction Therapeutics Market Research Report
By Type
CM-1212, CTDP-002, A-705253, ABT-436, ADX-71441, Others
By Application
Hospital, Clinic, Others
By Companies
AstraZeneca Plc, BioCorRx Inc, Bionex Pharmaceuticals LLC, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Curemark LLC, Eli Lilly and Company, Ethypharm SA, H. Lundbeck A/S, Heptares Therapeutics Ltd, Indivior Plc, Kinnov Therapeutics SAS, Kyorin Pharmaceutical Co Ltd, Lohocla Research Corp, Montisera Ltd, Omeros Corp, Opiant Pharmaceuticals Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Alcohol Addiction Therapeutics Market Report Segments:
The global Alcohol Addiction Therapeutics market is segmented on the basis of:
Types
CM-1212, CTDP-002, A-705253, ABT-436, ADX-71441, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca Plc
- BioCorRx Inc
- Bionex Pharmaceuticals LLC
- Cerecor Inc
- Chronos Therapeutics Ltd
- Corcept Therapeutics Inc
- Curemark LLC
- Eli Lilly and Company
- Ethypharm SA
- H. Lundbeck A/S
- Heptares Therapeutics Ltd
- Indivior Plc
- Kinnov Therapeutics SAS
- Kyorin Pharmaceutical Co Ltd
- Lohocla Research Corp
- Montisera Ltd
- Omeros Corp
- Opiant Pharmaceuticals Inc
Highlights of The Alcohol Addiction Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CM-1212
- CTDP-002
- A-705253
- ABT-436
- ADX-71441
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alcohol Addiction Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alcohol addiction therapies are treatments that help people who have an alcohol addiction. These treatments can include counseling, group therapy, and medication.
Some of the major players in the alcohol addiction therapeutics market are AstraZeneca Plc, BioCorRx Inc, Bionex Pharmaceuticals LLC, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Curemark LLC, Eli Lilly and Company, Ethypharm SA, H. Lundbeck A/S, Heptares Therapeutics Ltd, Indivior Plc, Kinnov Therapeutics SAS, Kyorin Pharmaceutical Co Ltd, Lohocla Research Corp, Montisera Ltd, Omeros Corp, Opiant Pharmaceuticals Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alcohol Addiction Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alcohol Addiction Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alcohol Addiction Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alcohol Addiction Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alcohol Addiction Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Alcohol Addiction Therapeutics Market Size and Y-o-Y Growth
4.5.2 Alcohol Addiction Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 CM-1212
5.2.2 CTDP-002
5.2.3 A-705253
5.2.4 ABT-436
5.2.5 ADX-71441
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alcohol Addiction Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alcohol Addiction Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 CM-1212
9.6.2 CTDP-002
9.6.3 A-705253
9.6.4 ABT-436
9.6.5 ADX-71441
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 CM-1212
10.6.2 CTDP-002
10.6.3 A-705253
10.6.4 ABT-436
10.6.5 ADX-71441
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 CM-1212
11.6.2 CTDP-002
11.6.3 A-705253
11.6.4 ABT-436
11.6.5 ADX-71441
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 CM-1212
12.6.2 CTDP-002
12.6.3 A-705253
12.6.4 ABT-436
12.6.5 ADX-71441
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 CM-1212
13.6.2 CTDP-002
13.6.3 A-705253
13.6.4 ABT-436
13.6.5 ADX-71441
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alcohol Addiction Therapeutics Market: Competitive Dashboard
14.2 Global Alcohol Addiction Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca Plc
14.3.2 BioCorRx Inc
14.3.3 Bionex Pharmaceuticals LLC
14.3.4 Cerecor Inc
14.3.5 Chronos Therapeutics Ltd
14.3.6 Corcept Therapeutics Inc
14.3.7 Curemark LLC
14.3.8 Eli Lilly and Company
14.3.9 Ethypharm SA
14.3.10 H. Lundbeck A/S
14.3.11 Heptares Therapeutics Ltd
14.3.12 Indivior Plc
14.3.13 Kinnov Therapeutics SAS
14.3.14 Kyorin Pharmaceutical Co Ltd
14.3.15 Lohocla Research Corp
14.3.16 Montisera Ltd
14.3.17 Omeros Corp
14.3.18 Opiant Pharmaceuticals Inc
